Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01781026
Title Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications

melanoma

Therapies

Vemurafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST